Appeals Court Invalidates Bristol-Myers Squibb's Hep B Patent

, The Litigation Daily

   | 1 Comments

In a win for the generic drug company Teva Pharmaceuticals and its lawyers at Winston & Strawn, the Federal Circuit knocked out a Bristol-Myers Squibb patent on the Hepatitis B drug Baraclude.

What's being said

  • bhanu

    Good Article

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202659214256

Thank you!

This article's comments will be reviewed.